Arteriocyte Medical Systems, Inc. Announces Strategic Investment in Control Medical Technology

CLEVELAND--(BUSINESS WIRE)--Arteriocyte Medical Systems announced today a strategic investment in Control Medical Technology, a medical device developer based in Park City, Utah. The investment will enable development and distribution of Control’s ASPIRE handheld disposable aspiration system for use with Arteriocyte Medical’s STEM-PREP and other Magellan®-platform technologies. The two companies will develop the ASPIRE system for surgical applications including bone marrow aspiration and disc decompression. Arteriocyte Medical Systems will serve as the exclusive U.S. orthopedic distributor for the ASPIRE bone marrow aspiration and disc decompression devices.